摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,5-三乙酰基-2-脱氧-beta-D-赤式戊呋喃糖 | 96291-75-7

中文名称
1,3,5-三乙酰基-2-脱氧-beta-D-赤式戊呋喃糖
中文别名
——
英文名称
1,3,5-tri-O-acetyl-2-deoxy-β-D-ribofuranose
英文别名
1,3,5-O-triacetyl-2-deoxyribose;2-Desoxy-β-D-ribofuranosid-1,3,5-triacetat;1,3,5-Triacetyl-2-desoxy-β-D-ribofuranose;1,3,5-Tri-O-acetyl-2-desoxy-β-D-ribofuranose;1,3,4-tri-O-acetyl-2-deoxy-β-D-erythro-pentopyranose;1,3,5-Tri-O-acetyl-2-deoxy-beta-D-erythro-pentofuranose;[(2R,3S,5S)-3,5-diacetyloxyoxolan-2-yl]methyl acetate
1,3,5-三乙酰基-2-脱氧-beta-D-赤式戊呋喃糖化学式
CAS
96291-75-7
化学式
C11H16O7
mdl
——
分子量
260.244
InChiKey
QAGMBTAACMQRSS-HBNTYKKESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    329.3±42.0 °C(Predicted)
  • 密度:
    1.24±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    18
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    88.1
  • 氢给体数:
    0
  • 氢受体数:
    7

SDS

SDS:38272916e0f3cdd22269a2fd78544b7f
查看

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Ultrasound-assisted one-pot synthesis of anti-CML nucleosides featuring 1,2,3-triazole nucleobase under iron-copper catalysis
    摘要:
    A simple and efficient synthesis of modified 1,2,3-triazole nucleosides was developed. The strategy involved sequential one-pot acetylation-azidation-cycloaddition procedure and was found to be highly effective under a cooperative effect of ultrasound activation and iron/copper catalysis. The reactions were carried out under both conventional and ultrasonic irradiation conditions. In general, improvement in rates and yields were observed when reactions were carried out under sonication compared with conventional conditions. This one-pot procedure provides several advantages such as operational simplicity, high yield, safety and environment friendly protocol. The resulting substituted nucleosides were evaluated for their anticancer activity against K562 chronic myelogenous leukemia (CML) cell line Crown Copyright (C) 2012 Published by Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ultsonch.2012.04.007
  • 作为产物:
    描述:
    2-deoxy-D-ribose4-二甲氨基吡啶 作用下, 以 2-甲基四氢呋喃 为溶剂, 以20%的产率得到
    参考文献:
    名称:
    Green Methods of Carbohydrate Acetylation
    摘要:
    Methods of carbohydrate acetylation are disclosed. A method may include adding a carbohydrate to a reaction vessel, adding poly-4-vinylpyriding (P4VP) to the reaction vessel, adding a bio-derived solvent to the reaction vessel, adding acetic anhydride (Ac20) to the reaction vessel, and adding a catalyst to the reaction vessel. The bio-derived solvent may be 2-methyltetrahydrofuran (2-MeTHF). A catalyst may also be added to the reaction vessel.
    公开号:
    US20230132332A1
点击查看最新优质反应信息

文献信息

  • Modified Nucleotides as Substrates of Terminal Deoxynucleotidyl Transferase
    作者:Daiva Tauraitė、Jevgenija Jakubovska、Julija Dabužinskaitė、Maksim Bratchikov、Rolandas Meškys
    DOI:10.3390/molecules22040672
    日期:——
    The synthesis of novel modified nucleotides and their incorporation into DNA sequences opens many possibilities to change the chemical properties of oligonucleotides (ONs), and, therefore, broaden the field of practical applications of modified DNA. The chemical synthesis of nucleotide derivatives, including ones bearing thio-, hydrazino-, cyano- and carboxy groups as well as 2-pyridone nucleobase-containing
    新型修饰核苷酸的合成及其掺入DNA序列为改变寡核苷酸(ON)的化学性质提供了许多可能性,因此,拓宽了修饰DNA的实际应用领域。进行了核苷酸衍生物化学合成,包括带有基,基,基和羧基基团的衍生物以及含2-吡啶酮核碱基的核苷酸。测试了制备的化合物作为末端脱氧核苷酸转移酶(TdT)的底物。含有N +-胞嘧啶,4-尿嘧啶以及2-吡啶酮,4--和4--2-吡啶酮作为核碱基的核苷酸被TdT接受,因此可以进行3'-末端修饰的ONs的酶促合成。成功进行了紫外线诱导的含4-尿嘧啶的ONs与TdT的交联。
  • [EN] ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE<br/>[FR] ANALOGUES D'ADÉNOSINE POUR LE TRAITEMENT D'UNE MALADIE
    申请人:BIOINTERVENE INC
    公开号:WO2020247546A1
    公开(公告)日:2020-12-10
    The disclosure provides adenosine analogs for the treatment of disease such as pain and inflammatory conditions.
    该披露提供了用于治疗疾病,如疼痛和炎症症状的腺苷类似物。
  • CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION
    申请人:Shanghai de Novo Pharmatech Co., Ltd.
    公开号:EP3854799A1
    公开(公告)日:2021-07-28
    A cyclic dinucleotide analogue, a pharmaceutical composition thereof, and application. A cyclic dinucleotide analogue (I), an isomer thereof, a prodrug, a stable isotope derivative, or a pharmaceutically acceptable salt has the following structure. The cyclic dinucleotide analogue can be used as a regulator of a stimulator of interferon genes (STING) and a related signal path thereof, and can effectively treat and/or relieve multiple types of diseases, including but not limited to malignant tumors, inflammations, autoimmune diseases, and infectious diseases. In addition, the STING regulator can also be used as a vaccine adjuvant.
    一种环二核苷酸类似物、其药物组合物及应用。一种环二核苷酸类似物(I)、其异构体、原药、稳定同位素衍生物或药学上可接受的盐具有如下结构。环二核苷酸类似物可用作干扰素基因刺激物(STING)及其相关信号通路的调节剂,可有效治疗和/或缓解多种类型的疾病,包括但不限于恶性肿瘤、炎症、自身免疫性疾病和传染性疾病。此外,STING 调节剂还可用作疫苗佐剂。
  • [EN] CD73 INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF<br/>[FR] INHIBITEUR DE CD73, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 一种CD73抑制剂,其制备方法和应用
    申请人:ABBISKO THERAPEUTICS CO LTD
    公开号:WO2020221209A1
    公开(公告)日:2020-11-05
    一种具有式(I)结构的CD73抑制剂,其制备方法和应用。系列化合物可广泛应用于制备治疗至少部分由CD73介导的癌症或肿瘤、自身免疫性疾病及紊乱、代谢性疾病的药物,特别是治疗黑色素瘤、结肠癌、胰腺癌、乳腺癌、前列腺癌、肺癌、白血病、脑瘤、淋巴瘤、卵巢癌和卡波西氏肉瘤的药物,有望开发成新一代CD73抑制剂药物。
  • Sono-Transition-Metal Catalysis of One-Pot Three-Step Synthesis of Glycosyl-1,2,3-triazoles
    作者:Mohsine Driowya、Khalid Bougrin、Rachid Benhida
    DOI:10.1080/00397911.2012.673043
    日期:2013.7.3
    As a continuation of our studies directed at the development of straightforward and sustainable methodologies, we describe herein an original example of a combined effect of ultrasonic activation and iron-copper dual catalysis that allows an efficient and ecofriendly one-pot, three-step route to a new series of nucleoside-substituted triazoles. The reactions were carried out under both conventional and ultrasonic irradiation conditions.Supplemental materials are available for this article. Go to the publisher's online edition of Synthetic Communications (R) to view the free supplemental file.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸